Eli Lilly: Bearish Signals Loom Over Weight Loss Stock Ahead Of Q2 Earnings
Eli Lilly: Bearish Signals Loom Over Weight Loss Stock Ahead Of Q2 Earnings
Eli Lilly and Co (NYSE:LLY) will be reporting its second-quarter earnings on Thursday. Wall Street expects $2.70 in EPS and $9.9 billion in revenues as the company reports before market hours.
礼来（纽交所: LLY）将在周四发布其第二季度业绩报告。华尔街预计公司报告发布前的市场交易时间，每股收益为2.70美元，营收为99亿美元。
The stock is up 69% over the past year, and has gained 30% YTD.
该股票过去一年上涨了69%，今年迄今已上涨30%。
Let's look at what the charts indicate for Eli Lilly stock, and how the stock currently maps against Wall Street estimates.
让我们看看Eli Lilly股票的图示，以及该股票目前与华尔街估值的对应关系。
Eli Lilly Stock Faced Potential Downside Risk Ahead Of Q2 Earnings...
Eli Lilly股票在Q2业绩公布之前面临潜在的下行风险......
Eli Lilly's stock is currently exhibiting a strongly bearish trend, as the share price is trading below its 5, 20, and 50-day exponential moving averages. This downward momentum is creating slight selling pressure.
Eli Lilly的股票目前呈强烈的看淡趋势，因为股价正在交易其5天、20天和50天的指数移动平均线以下。这种下行势头正在产生轻微的卖压。
Chart created using Benzinga Pro
使用Benzinga Pro创建的图表
Eli Lilly stock is priced at $770.02, which is below its 8-day simple moving average of $797.20, signaling a bearish outlook. Additionally, the stock is trading beneath its 20-day and 50-day simple moving averages, which are at $849.71 and $865.45, respectively, further supporting a bearish technical stance.
Eli Lilly股票的价格为770.02美元，低于其8日简单移动平均线的797.20美元，表明看淡前景。此外，该股票交易在其20日和50日简单移动平均线以下，分别为849.71美元和865.45美元，进一步支持看淡的技术立场。
However, the stock is above its 200-day simple moving average of $729.47, indicating a bullish signal in the long term.
然而，该股票高于其200日简单移动平均线729.47美元，表明长期存在看好信号。
Read Also: What's Going On With Eli Lilly And Company Shares Wednesday?
阅读更多: Eli Lilly and Company周三股票发生了什么？
Chart created using Benzinga Pro
使用Benzinga Pro创建的图表
The Moving Average Convergence Divergence (MACD) indicator stands at -27.32, reinforcing the bearish sentiment, while the Relative Strength Index (RSI) is at 34.58, suggesting that Eli Lilly stock is approaching oversold territory. The Bollinger Bands, ranging from $744.82 to $982.96, suggest that Eli Lilly is currently facing a bearish market environment.
移动平均线收敛/发散（MACD）指标为-27.32，强化了看淡态势，而相对强弱指数（RSI）为34.58，表明Eli Lilly股票正在接近超卖区域。布林带范围从744.82美元到982.96美元，表明Eli Lilly目前处于看淡的市场环境。
This combination of technical indicators points to potential downside risk in the short term, despite the long-term upside implied by the 200-day moving average.
这些技术指标的结合表明，尽管200日移动平均线暗示长期上涨，但在短期内存在潜在的下行风险。
Yet Analysts See About 15% Upside
然而，分析师仍看涨15%左右。
Ratings & Consensus Estimates: The consensus analyst rating on Eli Lilly stock stands at a Buy with a price target of $795.81. The three most recent analyst ratings for Eli Lilly stock were released by Guggenheim and Cantor Fitzgerald have an average price target of $884.67, suggesting a potential 14.84% upside for the stock.
评级与共识预估: Eli Lilly股票的共识分析师评级为买入，目标价为795.81美元。Guggenheim和Cantor Fitzgerald最近的三个分析师评级平均目标价为884.67美元，表明该股票可能上涨14.84%。
LLY Price Action: Eli Lilly stock was down 3.2% at $766.52 at the time of publication Wednesday.
LLY股票行情: Eli Lilly的股票在周三发布时下跌3.2%，报766.52美元。
- Novo Nordisk Tumbles 3% In Wednesday Premarket: What's Causing 'Miracle' Weight Loss Drug Ozempic Maker's Stock Slide?
- 诺和诺德周三盘前下跌3%：是什么导致奇迹减肥药欧赛昔单抗制造商股票下跌？
Photo: rafapress/Shutterstock.com
照片：rafapress/Shutterstock。